TD Cowen Reiterates Buy Rating on Marinus Pharmaceuticals (MRNS) Sep 23, 2024 07:39AM
TD Cowen Reiterates Buy Rating on Marinus Pharmaceuticals (MRNS) Aug 14, 2024 02:17PM
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Feb 21, 2024 07:00AM
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Feb 7, 2023 07:15AM
Cowen Reiterates Marinus Pharmaceuticals (MRNS) at Outperform Following Ztalmy Approval Mar 21, 2022 12:18PM


Feb 23, 2022 05:29AM Marinus (MRNS) Reiterated at Outperform by Cowen, RAISE Delay is Unfortunate, but Shares Undervalued on ganaxolone Potential
Jun 15, 2021 07:06AM Marinus Pharmaceuticals (MRNS) Highlighted as Best Biotech SMidcap Idea at Cowen
Feb 17, 2021 07:00AM Marinus Pharmaceuticals to Participate in Multiple Investor Healthcare and Life Sciences Conferences
Jul 1, 2020 09:28AM Pre-Open Stock Movers 07/01: (TTOO) (BYND) (PFE) Higher; (CHMA) (INO) (DENN) Lower (more...)
Jul 1, 2020 05:52AM Cowen Starts Marinus Pharmaceuticals (MRNS) at Outperform
Jun 2, 2020 04:01PM Marinus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 29, 2020 05:51AM Marinus Pharma (MRNS) Prices 16M Share Common Offering at $2.50/Sh
May 28, 2020 09:23PM Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
May 28, 2020 04:01PM Marinus Pharma (MRNS) to Offer Common Stock
May 28, 2020 04:01PM Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Feb 24, 2020 07:30AM Marinus Pharmaceuticals to Participate at Three Upcoming Investor Healthcare Conferences
Mar 5, 2019 07:30AM Marinus Pharmaceuticals to Present at the Cowen Healthcare Conference
Mar 1, 2016 07:30AM Marinus Pharmaceuticals to Present at the Cowen & Company Annual Healthcare Conference
Feb 24, 2015 07:30AM Marinus Pharmaceuticals to Participate in Cowen & Company Annual Healthcare Conference